Role of nuclear factor-kappaB in the immune system and bone.
about
CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptorNuclear receptors in bone physiology and diseasesReal-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models.Molecular determinants of the cardiometabolic phenotype.Transcriptional regulation of bone and joint remodeling by NFATWnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-κB.Applications of chitin and its derivatives in biological medicine.Association of toll-like receptor 5 gene polymorphism with susceptibility to ossification of the posterior longitudinal ligament of the spine in korean populationNovel functions for NFκB: inhibition of bone formationOsteopetrosis in TAK1-deficient mice owing to defective NF-κB and NOTCH signaling.Local administration of IKK small molecule inhibitor may enhance fracture healing in osteoporosis patientThe anti-inflammatory role of vitamin e in prevention of osteoporosis.Evaluating Nuclear Factor NF-κB Activation following Bone Trauma: A Pilot Study in a Wistar Rats ModelRenal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- miceThe human cytomegalovirus virion possesses an activated casein kinase II that allows for the rapid phosphorylation of the inhibitor of NF-kappaB, IkappaBalpha.Signaling networks that control the lineage commitment and differentiation of bone cells.Bojesodok-eum, a Herbal Prescription, Ameliorates Acute Inflammation in Association with the Inhibition of NF-κB-Mediated Nitric Oxide and ProInflammatory Cytokine Production.Novel therapies for rheumatoid arthritis.Roots of Erigeron annuus Attenuate Acute Inflammation as Mediated with the Inhibition of NF- κ B-Associated Nitric Oxide and Prostaglandin E2 production.Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-kappaB-dependent iNOS and proinflammatory cytokines production.Ubiquitin-like domain of IKKβ regulates osteoclastogenesis and osteolysisRole of the NF-kappaB axis in immune modulation of osteoclasts and bone loss.Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management.Synergistic induction of CX3CL1 by TNF alpha and IFN gamma in osteoblasts from rheumatoid arthritis: involvement of NF-kappa B and STAT-1 signaling pathways.Aldose reductase participates in the downregulation of T cell functions due to suppressor macrophages.Nuclear receptor retinoid-related orphan receptor α1 modulates the metabolic activity of human osteoblasts.Procyanidin dimer B1 and trimer C1 impair inflammatory response signalling in human monocytes.Activation of transcription factors by extracellular nucleotides in immune and related cell types.Staphylococcal enterotoxin C1-induced pyrogenic cytokine production in human peripheral blood mononuclear cells is mediated by NADPH oxidase and nuclear factor-kappa B.Activation of NF-kappaB by fluid shear stress, but not TNF-alpha, requires focal adhesion kinase in osteoblasts.Diclofenac sodium inhibits NFkappaB transcription in osteoclasts.Modulation of the peripheral immune system after low-dose radon spa therapy: Detailed longitudinal immune monitoring of patients within the RAD-ON01 study.Evaluation of NFKB1A variants in patients with knee osteoarthritis.LRRC15 promotes osteogenic differentiation of mesenchymal stem cells by modulating p65 cytoplasmic/nuclear translocation.Disruption of NF-κB1 prevents bone loss caused by mechanical unloading.Fraxinellone Attenuates Rheumatoid Inflammation in Mice.
P2860
Q24297284-8B4A5521-2023-4F24-B08F-12B4B8AF693BQ26853017-A2B08219-1EF4-43D9-830C-01ED6A766655Q33795121-9ED7CA07-4BC6-4F39-B374-76FB16A7E095Q33921392-0544DF75-9DB3-40B7-9F35-2B3493699A61Q33998768-DC9A91C2-D30C-49B6-982B-B4DC31AF72FAQ34156626-F9A875F0-18AE-49A4-8436-D4167FDFE936Q34187459-9700A345-B270-479E-9E46-ABCF49526A3AQ34762599-DAD0FB3D-10DC-4220-A0E6-43A8DF56EC1BQ34806538-0959667E-D964-4604-9498-B1AA868048B0Q34926779-85A12B3D-E072-4D39-8B7E-91518C69383EQ35173936-59CF1CC3-68B6-482D-B00D-702732DEE281Q35580008-61FDBD2B-747F-4EDD-862C-EA4C4711FFC6Q35806083-19F49253-0F58-425D-AD56-8DA45774F31DQ35855605-5228ED13-14D8-4BBF-880E-98BEF2615EB3Q35857513-36D00FDA-3D17-45E4-BA47-5C11B8CBBBBBQ36082866-9F2D285B-E4F8-4DB6-A25A-18098B98FB7DQ36321578-B6A2F63F-1D50-411B-AF79-078F445ADCFBQ36623081-2EC0AABB-8104-4930-BB40-4EA4DBE00507Q36679103-5CAC6F12-CA2B-4BCF-8108-F3E42C1EF09AQ36735829-AD15FCB9-0AC3-453E-8E39-7FC949C20FB0Q36996420-C9DE01DD-E999-40ED-BB2C-6A0ACEB87A2FQ37118770-FF5C27E8-216C-43DA-95CB-C1D789EEFA89Q37880077-2C657A6E-3E91-4F5E-BD89-A9B2340B36B1Q38294927-37E8743F-FABA-48C0-82B4-465CBC7889E1Q38381878-8AF33E17-0D72-4C7D-9BDF-A5CADE3B5990Q39561045-DF82C8C5-F854-4D3D-9317-F7302595C26AQ39575955-139EFAD3-8958-48CE-95BA-3842CF57B4E6Q40103919-461A5D4F-2448-4386-8FC7-D6DCC8421222Q40445480-F60B5F86-3DFF-43B0-87E4-ED9569E058BFQ41411791-61F87786-D0F7-4C26-88A6-476A24CB4FA7Q43261393-90939569-8C1E-4FA1-A310-F906BE3F48ABQ50860416-44438D6B-4AA9-4285-B7E7-94A5768A3266Q51294507-7C044D3C-5728-4353-BE05-4D17612B0B61Q51417792-2C562A76-5CCE-460E-A381-61BFC46AB5C6Q52633378-87AB0575-1D17-451A-9A5A-2D36CC9BA332Q52658060-AB31093B-FCF2-45C1-AA3B-D58CA27BA82D
P2860
Role of nuclear factor-kappaB in the immune system and bone.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Role of nuclear factor-kappaB in the immune system and bone.
@ast
Role of nuclear factor-kappaB in the immune system and bone.
@en
type
label
Role of nuclear factor-kappaB in the immune system and bone.
@ast
Role of nuclear factor-kappaB in the immune system and bone.
@en
prefLabel
Role of nuclear factor-kappaB in the immune system and bone.
@ast
Role of nuclear factor-kappaB in the immune system and bone.
@en
P2860
P1476
Role of nuclear factor-kappaB in the immune system and bone.
@en
P2093
Eijiro Jimi
Sankar Ghosh
P2860
P356
10.1111/J.0105-2896.2005.00329.X
P577
2005-12-01T00:00:00Z